Resource utilization in patients with large B-cell lymphoma receiving tisagenlecleucel and axicabtagene ciloleucel

被引：1
|
作者：
Mian, Agrima [1 ]
Wei, Wei [2 ]
Hamilton, Betty K. [3 ]
Winter, Allison M. [3 ]
Khouri, Jack [3 ]
Pohlman, Brad [3 ]
Gerds, Aaron T. [3 ]
Jagadeesh, Deepa [3 ]
Anwer, Faiz [3 ]
Kalaycio, Matt [3 ]
Dean, Robert M. [3 ]
Sobecks, Ronald [3 ]
Caimi, Paolo F. [3 ]
Hill, Brian T. [3 ]
Majhail, Navneet S. [4 ]
机构：
[1] Cleveland Clin, Dept Internal Med, Cleveland, OH USA
[2] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH USA
[3] Cleveland Clin, Dept Hematol & Med Oncol, Blood & Marrow Transplant Program, Cleveland, OH USA
[4] Sarah Cannon, Nashville, TN 37203 USA
来源：
BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / 05期
关键词：
TRANSPLANTATION; OUTCOMES; THERAPY;
D O I：
10.1038/s41409-023-01934-4
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：590 / 593
页数：4
相关论文
共 50 条
  • [41] Safety of axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma in an elderly intercity population
    Lauren C. Shapiro
    Jennat Mustafa
    Amanda Lombardo
    Fariha Khatun
    Felisha Joseph
    Kailyn Gillick
    Anjali Naik
    Richard Elkind
    Michelly Abreu
    Karen Fehn
    Alyssa de Castro
    Kith Pradhan
    Donika Binakaj
    Randin Nelson
    Monika Paroder
    Joan Uehlinger
    Kira Gritsman
    R. Alejandro Sica
    Noah Kornblum
    Aditi Shastri
    Ioannis Mantzaris
    Lizamarie Bachier-Rodriguez
    Amit Verma
    Ira Braunschweig
    Mendel Goldfinger
    Bone Marrow Transplantation, 2021, 56 : 1761 - 1763
  • [42] Tisagenlecleucel in Diffuse Large B-Cell Lymphoma
    Schwartz, Jonathan D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (16): : 1585 - 1586
  • [43] A Multicenter Real-life Prospective Study of Axicabtagene Ciloleucel versus Tisagenlecleucel Toxicity and Outcomes in Large B-cell Lymphomas
    Stella, Federico
    Chiappella, Annalisa
    Casadei, Beatrice
    Bramanti, Stefania
    Ljevar, Silva
    Chiusolo, Patrizia
    Di Rocco, Alice
    Tisi, Maria C.
    Carrabba, Matteo G.
    Cutini, Ilaria
    Martino, Massimo
    Dodero, Anna
    Bonifazi, Francesca
    Santoro, Armando
    Sora, Federica
    Botto, Barbara
    Barbui, Anna M.
    Russo, Domenico
    Musso, Maurizio
    Grillo, Giovanni
    Krampera, Mauro
    Olivieri, Jacopo
    Ladetto, Marco
    Cavallo, Federica
    Massaia, Massimo
    Arcaini, Luca
    Pennisi, Martina
    Zinzani, Pier L.
    Miceli, Rosalba
    Corradini, Paolo
    BLOOD CANCER DISCOVERY, 2024, 5 (05): : 318 - 330
  • [44] Outcomes of older patients in ZUMA-1, a pivotal study of axicabtagene ciloleucel in refractory large B-cell lymphoma
    Neelapu, Sattva S.
    Jacobson, Caron A.
    Oluwole, Olalekan O.
    Munoz, Javier
    Deol, Abhinav
    Miklos, David B.
    Bartlett, Nancy L.
    Braunschweig, Ira
    Jiang, Yizhou
    Kim, Jenny J.
    Zheng, Lianqing
    Rossi, John M.
    Locke, Frederick L.
    BLOOD, 2020, 135 (23) : 2106 - 2109
  • [45] Cost-Effectiveness of Axicabtagene Ciloleucel for Adult Patients with Relapsed or Refractory Large B-Cell Lymphoma in the United States
    Roth, Joshua
    Sullivan, Sean D.
    Lin, Vincent W.
    Purdum, Anna
    Navale, Lynn
    Cheng, Paul
    Ramsey, Scott D.
    BONE MARROW TRANSPLANTATION, 2018, 53 : 874 - 875
  • [46] Safety and efficacy of axicabtagene ciloleucel in refractory large B-cell lymphomas
    Riedell, Peter A.
    Bishop, Michael R.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2020, 11
  • [47] The impact of obesity and body weight on the outcome of patients with relapsed/refractory large B-cell lymphoma treated with axicabtagene ciloleucel
    Wudhikarn, Kitsada
    Bansal, Radhika
    Khurana, Arushi
    Hathcock, Matthew A.
    Bennani, N. Nora
    Paludo, Jonas
    Villasboas, Jose C.
    Wang, Yucai
    Johnston, Patrick B.
    Ansell, Stephen M.
    Lin, Yi
    BLOOD CANCER JOURNAL, 2021, 11 (07)
  • [48] Patterns of Use, Outcomes, and Resource Utilization among Recipients of Commercial Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed/Refractory Aggressive B Cell Lymphomas
    Riedell, Peter A.
    Hwang, Wei-Ting
    Nastoupil, Loretta J.
    Pennisi, Martina
    McGuirk, Joseph P.
    Maziarz, Richard T.
    Bachanova, Veronika
    Oluwole, Olalekan O.
    Brower, Jamie
    Flores, Oscar A.
    Ahmed, Nausheen
    Schachter, Levanto
    Bharucha, Kharmen
    Dholaria, Bhagirathbhai R.
    Schuster, Stephen J.
    Perales, Miguel-Angel
    Bishop, Michael R.
    Porter, David L.
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (10): : 669 - 676
  • [49] Earlier Steroid Use With Axicabtagene Ciloleucel (Axi-Cel) in Patients With Relapsed/Refractory Large B-Cell Lymphoma
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (02) : 12 - 14
  • [50] Real World of Experience Axicabtagene Ciloleucel for The Treatment of Relapsed or Refractory Large B-Cell Lymphoma in Spain
    Kwon, Mi
    Bailen, Rebeca
    Lopez Corral, Lucia
    Luis Reguera, Juan
    Iacoboni, Gloria
    Hernani Morales, Rafael
    Ortiz Maldonado, Valentin
    Bastos Oreiro, Mariana
    Martin Garcia, Alejandro
    Martinez Cibrian, Nuria
    Barba, Pere
    Delgado, Julio
    Jose Terol, Maria
    Diez Martin, Jose Luis
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 37 - 39
12345